Ixekizumab - Eli Lilly and Company
At a glance
- Drug Originator Eli Lilly and Company
- Drug Licenced by Torii Pharmaceutical
- Drug Class Anti-inflammatories; Antibodies; Antipsoriatics; Antirheumatics; Antiulcers; Monoclonal antibodies; Skin disorder therapies; Vascular disorder therapies
- Mechanism of Action IL17A protein inhibitors
- USA Patent Applicants ELI LILLY AND CO
- USA Patents 26
- BLAs 1
- International Patents 95

Disclaimer